Visit Rajant with UVify at Xponential Booth 1734 Malvern, PA – May 9, 2023: Rajant Corporation, the pioneer of Kinetic Mesh® wireless, will announce the integration of its latest credit card-sized dual-radio Cardinal module with UVify’s OMEGA drone platform at Xponential May 8th – 11th in Denver, Colorado. The Cardinal is powerful, lightweight, and notably… Read More »
Virtual event in October will allow leading Salesforce architects to discuss ideas, opportunities, and strategies to maximize the value of Salesforce data SAN FRANCISCO – JULY 21, 2022 – Odaseva, leading enterprise data platform for Salesforce, has announced the date for its two-day Data Innovation Forum, to be held on October 26-27, 2022. The stakes… Read More »
Integrated offering enables intelligent career sites that engage candidates and empower recruiters San Francisco – February 4, 2022 – SmartRecruiters, the Hiring Success company, today announces the acquisition of Attrax, an industry-leading provider of career site software that lets companies build engaging, personalized career sites. The acquisition will result in an integrated offering, SmartRecruiters Attrax,… Read More »
Hawick, Scotland, 6 January 2022 – Emtelle, the leading global manufacturer of blown fibre cable and ducted network solutions, is pleased to announce the appointment of Mark Van De Velde as sales director to serve the UK & Ireland. In his role, he will be responsible for developing sales strategies, creating new business opportunities, and… Read More »
Highlights Include Intelligent Automation Luminaries, Customer Panels, Product Demonstrations, Premium Content Access and Kofax Customer Excellence Awards London, UK – May 11, 2021 – Kofax®, a leading supplier of intelligent automation software for digital workflow transformation, today announces speakers and sessions for Kofax Accelerate, the immersive virtual customer event launching on May 25. Free registration… Read More »
STANS, Switzerland – January 29 2021 – NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces the pricing of its initial public offering of 4,819,277 units at a price… Read More »